Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
-$26M
Net insider buying / selling at Tarsus Pharmaceuticals (TARS) over the last 2 years. Updated Sep 17, 2026

Are Tarsus Pharmaceuticals Insiders Buying or Selling?

Tarsus Pharmaceuticals (TARS) has had 13 insider transactions in the past 90 days, all sells. The most recent was LINK WILLIAM J PHD, who sold 11,675 shares at $78.33 on September 15, 2026.

Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the TARS AI Score. For government officials trading this stock, see TARS congressional trading.

Who’s Trading Tarsus Pharmaceuticals Stock?

InsiderActivityTradesLast Trade
Bobak Azamian Sold $7.3M 16 Sep 4, 2026
LINK WILLIAM J PHD Sold $6M 14 Sep 15, 2026
Dianne Whitfield Sold $3M 11 Mar 19, 2026
Seshadri Neervannan Sold $2.4M 9 Sep 4, 2026
Lin Elizabeth Yeu Sold $2.3M 11 Sep 4, 2026
Aziz Mottiwala Sold $2.2M 7 Mar 19, 2026

Recent Tarsus Pharmaceuticals Insider Transactions

Insider Transaction Date Type Shares Price Value
LINK WILLIAM J PHDSep 15, 2026Sell11,675$78.33$910,000
LINK WILLIAM J PHDSep 15, 2026Sell759$79$60,000
LINK WILLIAM J PHDSep 15, 2026Sell66$80.01$5,300
Lin Elizabeth YeuSep 4, 2026Sell5,387$85$460,000
Lin Elizabeth YeuSep 4, 2026Sell5,386$90$480,000
Lin Elizabeth YeuSep 4, 2026Sell1,590$90$140,000
Bobak AzamianSep 4, 2026Sell7,100$90.27$640,000
Bobak AzamianSep 4, 2026Sell2,900$91.27$260,000
Seshadri NeervannanSep 4, 2026Sell4,564$85$390,000
Bobak AzamianSep 2, 2026Sell10,000$80.06$800,000
Lin Elizabeth YeuSep 2, 2026Sell5,387$80$430,000
Lin Elizabeth YeuSep 2, 2026Sell1,590$80$130,000
Lin Elizabeth YeuSep 1, 2026Sell4,601$73.86$340,000
Bobak AzamianJun 17, 2026Sell5,418$61.81$330,000
Bobak AzamianJun 17, 2026Sell4,582$61.24$280,000
Jeffrey FarrowJun 16, 2026Sell14,396$60.95$880,000
LINK WILLIAM J PHDJun 15, 2026Sell10,572$61.97$660,000
LINK WILLIAM J PHDJun 15, 2026Sell1,928$62.94$120,000
Seshadri NeervannanMar 20, 2026Sell2,989$66.75$200,000
Bobak AzamianMar 19, 2026Sell11,964$67$800,000
Bryan WahlMar 19, 2026Sell4,231$67$280,000
Dianne WhitfieldMar 19, 2026Sell4,174$67$280,000
Seshadri NeervannanMar 19, 2026Sell4,589$67$310,000
Aziz MottiwalaMar 19, 2026Sell4,440$67$300,000
Jeffrey FarrowMar 19, 2026Sell2,186$67$150,000
Lin Elizabeth YeuMar 19, 2026Sell390$67$26,000
Bobak AzamianMar 18, 2026Sell11,667$68.71$800,000
Bryan WahlMar 18, 2026Sell4,125$68.71$280,000
Dianne WhitfieldMar 18, 2026Sell4,071$68.71$280,000
Seshadri NeervannanMar 18, 2026Sell3,610$68.71$250,000
Aziz MottiwalaMar 18, 2026Sell4,330$68.71$300,000
Jeffrey FarrowMar 18, 2026Sell2,133$68.71$150,000
Lin Elizabeth YeuMar 18, 2026Sell379$68.71$26,000
Bobak AzamianMar 17, 2026Sell10,972$69.42$760,000
Bryan WahlMar 17, 2026Sell4,084$69.42$280,000
Dianne WhitfieldMar 17, 2026Sell4,029$69.42$280,000
Seshadri NeervannanMar 17, 2026Sell3,125$69.42$220,000
Aziz MottiwalaMar 17, 2026Sell4,286$69.42$300,000
Jeffrey FarrowMar 17, 2026Sell2,111$69.42$150,000
Lin Elizabeth YeuMar 17, 2026Sell375$69.42$26,000
LINK WILLIAM J PHDMar 16, 2026Sell8,378$69.03$580,000
LINK WILLIAM J PHDMar 16, 2026Sell3,629$68.09$250,000
LINK WILLIAM J PHDMar 16, 2026Sell493$69.75$34,000
Seshadri NeervannanMar 4, 2026Sell8,366$76.67$640,000
Dianne WhitfieldJan 2, 2026Sell8,122$80.71$660,000
Dianne WhitfieldJan 2, 2026Sell5,715$80.09$460,000
Dianne WhitfieldJan 2, 2026Sell893$82.93$74,000
Dianne WhitfieldJan 2, 2026Sell835$81.9$68,000
Bobak AzamianDec 24, 2025Sell5,443$82.41$450,000
Bobak AzamianDec 24, 2025Sell557$83.54$47,000
Lin Elizabeth YeuDec 16, 2025Sell2,078$79.5$170,000
Dianne WhitfieldDec 16, 2025Sell7,397$80.1$590,000
LINK WILLIAM J PHDDec 15, 2025Sell6,306$81.75$520,000
LINK WILLIAM J PHDDec 15, 2025Sell5,680$80.71$460,000
LINK WILLIAM J PHDDec 15, 2025Sell5,046$80.8$410,000
LINK WILLIAM J PHDDec 15, 2025Sell4,766$81.5$390,000
LINK WILLIAM J PHDDec 15, 2025Sell1,148$82.39$95,000
Bobak AzamianSep 24, 2025Sell6,000$55.37$330,000
LINK WILLIAM J PHDSep 8, 2025Sell27,116$57$1.5M
Bobak AzamianAug 11, 2025Sell6,000$50$300,000
Jeffrey FarrowJun 17, 2025Sell13,608$40.42$550,000
Lin Elizabeth YeuJun 16, 2025Sell1,006$41.08$41,000
Aziz MottiwalaJun 9, 2025Sell17,500$43.76$770,000
Bobak AzamianMar 24, 2025Sell6,000$50$300,000
Aziz MottiwalaMar 20, 2025Sell3,365$50.11$170,000
Seshadri NeervannanMar 20, 2025Sell2,435$50.11$120,000
Bryan WahlMar 20, 2025Sell3,084$50.11$150,000
Dianne WhitfieldMar 20, 2025Sell2,137$50.11$110,000
Bobak AzamianMar 20, 2025Sell8,534$50.11$430,000
Jeffrey FarrowMar 20, 2025Sell1,186$50.11$59,000
Aziz MottiwalaMar 19, 2025Sell3,557$47.4$170,000
Seshadri NeervannanMar 19, 2025Sell2,543$47.4$120,000
Bryan WahlMar 19, 2025Sell3,261$47.4$150,000
Dianne WhitfieldMar 19, 2025Sell2,259$47.4$110,000
Bobak AzamianMar 19, 2025Sell8,551$47.4$410,000
Jeffrey FarrowMar 19, 2025Sell1,254$47.4$59,000
Aziz MottiwalaMar 18, 2025Sell3,643$46.29$170,000
Seshadri NeervannanMar 18, 2025Sell2,605$46.29$120,000
Bryan WahlMar 18, 2025Sell3,341$46.29$150,000
Dianne WhitfieldMar 18, 2025Sell2,315$46.29$110,000
Bobak AzamianMar 18, 2025Sell7,131$46.29$330,000
Jeffrey FarrowMar 18, 2025Sell1,284$46.29$59,000

Frequently Asked Questions: Tarsus Pharmaceuticals Insider Trading

In the past 90 days, Tarsus Pharmaceuticals insiders have made 0 buys and 13 sells. The net selling may indicate insiders are taking profits or reducing exposure.

The most recent sale was by LINK WILLIAM J PHD who sold 11,675 shares on September 15, 2026. View all transactions in the table on this page.

Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.

Azamian Bobak R. has sold the most TARS stock in the last 2 years, with a total value of $7.3M.

The total value of insider transactions for Tarsus Pharmaceuticals in the last 2 years is negative, amounting to -$26M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.